Our Network
Cevaxin
Panama City, Panama
60+ studies, 20,000+ participants; strong invaccines, RSV, HIV
Specialties
Vaccines, infectious diseases, respiratory, HIV, HPV, pneumococcus, RSV
Key infrastructure:
- Medical offices, in-house pharmacy, and laboratory
- Monitoring room and informed consent facilities.
- Real-time management platform
Completed studies
- 60+clinical trials
- 20,000+participants
- Pediatric, adult, and pregnant populations
- Contributions to 10+vaccines now approved
CEIP
Cali, Colombia
50+ studies, 28,000+ participants; maternal-child health, community trials
Specialties
Vaccines, infectious diseases, maternal-child health, community-based studies
Key infrastructure:
- 14 consultation rooms, pharmacy, laboratory, and call center
- Resuscitation room and auditorium
- 85 °C freezers, cold storage units, and redundant connectivity systems
Completed studies
- 50+ clinical trials
- 28,000+ enrolled participants
- Contributions to 15 approved vaccines
CECLISA
Guatemala City, Guatemala
20+ studies; pediatrics, gastroenterology, advanced lab capacity
Specialties
Vaccines, pediatrics, respiratory diseases, gastroenterology
Key infrastructure:
- Pediatric and adult consultation rooms
- Laboratory with sample processing and PBMC capabilities
- Procedure and observation rooms
- 70 °C freezers and validated cold chain
Completed studies
- 20+ clinical trials
- Participation in phase II and III studies, including pediatric and COVID-19 vaccine trials
Policlínico Social del Norte
Bogotá, Colombia
6+ studies; gastro and respiratory; fast-track enrollment and strong infrastructure
Specialties
Vaccines, gastroenterology, respiratory health
Key infrastructure:
- Private IPS with over 30 years of clinical experience
- Research center approved by INVIMA
- Electronic medical records and fast-track enrollment capability
Completed studies
- 6+ clinical trials since 2021
- Record-setting enrollment in COVID-19 and RSV studies
Our Network
Cevaxin
Panama City, Panama
60+ studies, 20,000+ participants; strong invaccines, RSV, HIV
Specialties
Vaccines, infectious diseases, respiratory, HIV, HPV, pneumococcus, RSV
Key infrastructure:
- Medical offices, in-house pharmacy, and laboratory
- Monitoring room and informed consent facilities.
- Real-time management platform
Completed studies
- 60+clinical trials
- 20,000+participants
- Pediatric, adult, and pregnant populations
- Contributions to 10+vaccines now approved
CEIP
Cali, Colombia
50+ studies, 28,000+ participants; maternal-child health, community trials
Specialties
Vaccines, infectious diseases, maternal-child health, community-based studies
Key infrastructure:
- 14 consultation rooms, pharmacy, laboratory, and call center
- Resuscitation room and auditorium
- 85 °C freezers, cold storage units, and redundant connectivity systems
Completed studies
- 50+ clinical trials
- 28,000+ enrolled participants
- Contributions to 15 approved vaccines
CECLISA
Guatemala City, Guatemala
20+ studies; pediatrics, gastroenterology, advanced lab capacity
Specialties
Vaccines, pediatrics, respiratory diseases, gastroenterology
Key infrastructure:
- Pediatric and adult consultation rooms
- Laboratory with sample processing and PBMC capabilities
- Procedure and observation rooms
- 70 °C freezers and validated cold chain
Completed studies
- 20+ clinical trials
- Participation in phase II and III studies, including pediatric and COVID-19 vaccine trials
Policlínico Social del Norte
Bogotá, Colombia
6+ studies; gastro and respiratory; fast-track enrollment and strong infrastructure
Specialties
Vaccines, gastroenterology, respiratory health
Key infrastructure:
- Private IPS with over 30 years of clinical experience
- Research center approved by INVIMA
- Electronic medical records and fast-track enrollment capability
Completed studies
- 6+ clinical trials since 2021
- Record-setting enrollment in COVID-19 and RSV studies
Meet Our Experts
Dr. Rodrigo DeAntonio
Scientific Director at Cevaxin; leader in public health and vaccine research.
▾- MD, epidemiologist, Master in Health Economics, Doctor in Public Health, and Executive and Scientific Director at Cevaxin in Panama.
- Leads clinical and epidemiological research on vaccine-preventable diseases.
- Studies include rotavirus, pneumococcus, meningococcus, HPV, pertussis, hepatitis, RSV, influenza, chickenpox, norovirus, dengue, and COVID-19.
Dr. Xavier Saez Llorens
Pediatric infectious disease expert; research director at Hospital del Niño.
▾- Medical degree from the University of Panama, with postdoctoral training in Pediatrics (Panama) and Infectious Diseases (UT Southwestern, USA).
- Professor of Pediatrics, Chief of Infectious Diseases, and Director of Clinical Research at Hospital del Niño Dr. José Renán Esquivel.
- Distinguished investigator (Senacyt, Cevaxin), advisor for Panama’s COVID-19 vaccination efforts, and member of various ethics and scientific committees.
Dr. Eduardo Lopez-Medina
Director at CEIP; specialist in pediatric vaccines and global research.
▾- Physician trained at Universidad del Valle (Colombia), pediatric residency at Miami Children’s Hospital, and fellowship at University of Texas.
- Master’s in Epidemiology (University of London) and clinical research program at Harvard.
- Research on vaccine-preventable diseases and infections in immunocompromised children; widely published in scientific journals.
Dr. Mario Melgar
Director at CECLISA; leads pediatric oncology and infectious disease studies.
▾- Pediatric infectious diseases specialist trained at Federico Gómez Children’s Hospital (Mexico).
- Heads Pediatric Infectious Diseases at Roosevelt Hospital and Guatemala’s National Pediatric Oncology Unit.
- Director of CECLISA, running Phase I–III clinical trials in vaccines, rheumatology, oncology, and more.
Dr. Gabrielle Britton
Executive Director of Cevaxin Neuroscientist specializing in aging, mental health, and neurodegeneration.
▾PhD in Psychology and Neuroscience. She has coordinated projects funded by SENACYT, EULAC, and BID, focusing on brain health and aging in adults. Creator of the longitudinal study Panama Aging Research Initiative – Health Disparities (PARI-HD) at INDICASAT AIP Research field: Alzheimer's Cognitive impairment Mental health in adults COVID-19 and cognitive function Health disparities and aging
Dr. Pío López
General Director of the Center for Studies in Pediatric Infectious Diseases (CEIP)
▾- Infectious disease specialist and pediatrician. - General Director of the Center for Studies in Pediatric Infectious Diseases (CEIP), Cali, Colombia.
- Former President of the Colombian Association of Infectious Diseases (ACIN) for the terms 2015–2017 and 2017–2019.
- Former President of the Latin American Society for Pediatric Infectious Diseases (SLIPE) from 2019 to 2021.
Meet Our Experts
Dr. Rodrigo DeAntonio
Scientific Director at Cevaxin; leader in public health and vaccine research.
▾- MD, epidemiologist, Master in Health Economics, Doctor in Public Health, and Executive and Scientific Director at Cevaxin in Panama.
- Leads clinical and epidemiological research on vaccine-preventable diseases.
- Studies include rotavirus, pneumococcus, meningococcus, HPV, pertussis, hepatitis, RSV, influenza, chickenpox, norovirus, dengue, and COVID-19.
Dr. Xavier Saez Llorens
Pediatric infectious disease expert; research director at Hospital del Niño.
▾- Medical degree from the University of Panama, with postdoctoral training in Pediatrics (Panama) and Infectious Diseases (UT Southwestern, USA).
- Professor of Pediatrics, Chief of Infectious Diseases, and Director of Clinical Research at Hospital del Niño Dr. José Renán Esquivel.
- Distinguished investigator (Senacyt, Cevaxin), advisor for Panama’s COVID-19 vaccination efforts, and member of various ethics and scientific committees.
Dr. Eduardo Lopez-Medina
Director at CEIP; specialist in pediatric vaccines and global research.
▾- Physician trained at Universidad del Valle (Colombia), pediatric residency at Miami Children’s Hospital, and fellowship at University of Texas.
- Master’s in Epidemiology (University of London) and clinical research program at Harvard.
- Research on vaccine-preventable diseases and infections in immunocompromised children; widely published in scientific journals.
Dr. Mario Melgar
Director at CECLISA; leads pediatric oncology and infectious disease studies.
▾- Pediatric infectious diseases specialist trained at Federico Gómez Children’s Hospital (Mexico).
- Heads Pediatric Infectious Diseases at Roosevelt Hospital and Guatemala’s National Pediatric Oncology Unit.
- Director of CECLISA, running Phase I–III clinical trials in vaccines, rheumatology, oncology, and more.
Dr. Gabrielle Britton
Executive Director of Cevaxin Neuroscientist specializing in aging, mental health, and neurodegeneration.
▾PhD in Psychology and Neuroscience. She has coordinated projects funded by SENACYT, EULAC, and BID, focusing on brain health and aging in adults. Creator of the longitudinal study Panama Aging Research Initiative – Health Disparities (PARI-HD) at INDICASAT AIP Research field: Alzheimer's Cognitive impairment Mental health in adults COVID-19 and cognitive function Health disparities and aging
Dr. Pío López
General Director of the Center for Studies in Pediatric Infectious Diseases (CEIP)
▾- Infectious disease specialist and pediatrician. - General Director of the Center for Studies in Pediatric Infectious Diseases (CEIP), Cali, Colombia.
- Former President of the Colombian Association of Infectious Diseases (ACIN) for the terms 2015–2017 and 2017–2019.
- Former President of the Latin American Society for Pediatric Infectious Diseases (SLIPE) from 2019 to 2021.